Rebion

04/07/2022

https://www.newswire.com/news/rebion-awarded-1-0m-by-the-nih-to-study-longitudinal-monitoring-of-21678000

The National Institute of Neurological Disorders and Stroke has awarded Rebion a two-year, $1.0M SBIR grant to research traumatic brain injury monitoring

03/24/2022

David G. Hunter, MD, PhD Ophthalmologist-in-Chief at Boston Children's Hospital delivers an inspiring lecture that brought the audience on his career-long journey to develop and commercialize the blinq.® vision scanner. Direct detection of amblyopia and strabismus is now possible with the blinq.® vision scanner.

03/24/2022

Congrats David!

10/05/2021

Using the blinq device to detect common vision problems

http://ow.ly/1AO050GhBp1

09/28/2021

NIH-funded study shows screening device accurately detects amblyopia (lazy eye)

http://ow.ly/HVjz50GhB93

09/17/2021

Newly published clinical trial shows unprecedented accuracy of Rebion’s blinq® vision scanner in pediatric vision screening https://www.newswire.com/news/newly-published-clinical-trial-shows-unprecedented-accuracy-of-rebions-21501292

08/20/2021

See our ad in Contemporary Pediatrics

08/20/2021

Like our new BabySee page! https://www.facebook.com/BabySee-112409711040937

07/23/2021

Rebion's Neural Performance Scanning technology powers the blinq.® device for early identification of amblyopia (lazy eye) at Tampa Lions' Vision Health Program screenings.